<DOC>
	<DOCNO>NCT01569568</DOCNO>
	<brief_summary>The purpose study use various type MRI cognitive test evaluate change brain cognitive function occur subject ornithine transcarbamylase deficiency ( OTCD ) relative healthy individual</brief_summary>
	<brief_title>Investigation Brain Nitrogen Partial Ornithine Transcarbamylase Deficiency ( OTCD ) Using 1 H MRS , DTI , fMRI</brief_title>
	<detailed_description>The overall goal project characterize metabolic , structural cognitive change OTCD use 1H MRS , DTI , volumetric average fMRI cognitive test executive function measure validate biomarkers effect HA treatment brain . We measure gln mI blood brain ( use 1H MRS ) affect participant , mI brain control , fractional anisotropy measure white matter microstructural damage ( DTI ) brain activation pathway alteration task probe work memory ( fMRI ) . As secondary outcome measure , correlate finding neuroimaging cognitive functioning . This protocol base previous 5104 include child evaluate age stage disease indices cohort undergo important developmental event age match typically develop cohort .</detailed_description>
	<mesh_term>Ornithine Carbamoyltransferase Deficiency Disease</mesh_term>
	<criteria>Subject inclusion criterion : 1 . Patients OTCD ; 2 . Age range : 760 year 3 . Able undergo neuroimaging safely ( i.e . without presence ferromagnetic device ) 4 . Subject document full scale IQ &gt; 70 Control participant inclusion criterion : 1 . Healthy male female without metabolic disease age 760 year 2 . Subject document full scale IQ &gt; 70 Subject exclusion criterion : 1 . Mental retardation ( i.e. , Full Scale IQ &lt; 70 ) 2 . Age range &lt; 7 &gt; 60 year 3 . Presence ferromagnetic device ( ) preclude safe image 4 . Pregnant female Control exclusion criterion : 1 . Subjects document history intellectual deficit ( i.e. , Full Scale IQ &lt; 70 ) 2 . Age range &lt; 7 &gt; 60 year 3 . Presence ferromagnetic device ( ) preclude safe image 4 . Pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Neuroimaging</keyword>
	<keyword>MRI</keyword>
	<keyword>Urea cycle</keyword>
	<keyword>hyperammonemia</keyword>
	<keyword>cognitive function</keyword>
	<keyword>ornithine transcarbamylase deficiency</keyword>
</DOC>